Jonathan is a Senior Executive with extensive Leadership, Commercial and Financial experience. For over twenty years he has worked in the Medical Diagnostic field as Finance Director, CFO and VP & General Manager.Currently Jonathan holds the position of Group CFO after filling the role of ad interim CEO for the Silver Stream Nursing Home Group. Silver Stream was the first investment into Ireland by the very reputable and successful Waterland Private Equity, headquartered in The Netherlands. Prior to Silverstream Jonathan worked with Erba Diagnostics (a subsidiary of TransAsia Bio Medical based in Mumbai, India). At Erba he set-up the Corporate Finance Function in Dublin, acquiring offices and hiring a professional team to centralise the consolidation of Sales, Financial Performance, Compliance, and Internal Control.As VP and General Manager of DiaSorin Jonathan led an effective and consistently profitable site. He was responsible for ensuring competitive manufacturing across multiple technologies including Molecular Diagnostics & ELISA, delivery of the R&D pipeline, site profitability and regulatory compliance. In addition, he introduced a key supplier management program, developed a Leadership program for Senior Managers in conjunction with the IMI, and worked with HR to improve staff retention and motivation as part of his brief.At DiaSorin he led two financial due diligences processes, one for a €7m (Extraction business from Nordiag ASA in Norway) and one for a €58m (Murex business from Abbott Diagnostics in the UK) acquisition.Before his role with DiaSorin he held a Senior Management role in Biotrin International Limited, working with the Irish start-up until its successful sale to DiaSorin in 2008. During this period, he participated in a successful Management Buy Out (MBO) to purchase the business from the initial investors and venture capital institutions.Jonathan has worked with a high calibre business coach to build on his leadership experience. He is a member of the Institute of Directors in Ireland and has made significant contributions to the Irish Medical Device Association (IMDA) on R&D tax credits in Ireland. Jonathan also advises spin-out companies from various Irish universities (UCD, DCU and Trinity) on business planning and fund raising and has worked with the state agency, Enterprise Ireland (EI) as part of their start-up funding panel.